IA
SRNE

IndexIQ Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

IndexIQ Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$386K Buy
+165,463
New +$516K 0.01% 877

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

IndexIQ Advisors's SRNE Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Sorrento Therapeutics, Inc. (SRNE) in Q1 2022: 165,463 shares worth $386K. The stake represents 0.01% of the portfolio and ranks #877 among its holdings.

235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

  • IndexIQ Advisors held 165,463 shares of Sorrento Therapeutics, Inc. worth $386K as of Q1 2022.
  • Sorrento Therapeutics, Inc. was a new IndexIQ Advisors position in Q1 2022.
  • Sorrento Therapeutics, Inc. made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #877 holding.
  • 235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.